Sorry, no content matched your criteria.
Featured Story
Where a Teva-Mylan Deal Would Rank Among Big Pharma Companies
Two big pharma companies are in merger talks this week. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced Tuesday it's making a $40 billion bid for Mylan NV (Nasdaq: MYL).
Combined, the two firms would have revenue near $28 billion. That would make the company the ninth-largest pharmaceutical company in the world based on revenue.
Here's a look at the top 10 big pharma companies globally...
Two big pharma companies are in merger talks this week. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced Tuesday it's making a $40 billion bid for Mylan NV (Nasdaq: MYL).
Combined, the two firms would have revenue near $28 billion. That would make the company the ninth-largest pharmaceutical company in the world based on revenue.
Here's a look at the top 10 big pharma companies globally...